开云app官网登录入口网页版-官方正版

#糖尿病性视网膜病变#

10篇内容 | 1138人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1405609, encodeId=8c2014056092d, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=Diabetes Care：胰高血糖素样肽1受体激动剂与糖尿病性视网膜病变发生风险的关系, objectType=article, longId=216622, objectId=130b2166226e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=130b2166226e, replyNumber=0, likeNumber=68, createdTime=2021-09-04, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=130b2166226e, moduleTitle=Diabetes Care：胰高血糖素样肽1受体激动剂与糖尿病性视网膜病变发生风险的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=130b2166226e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405608, encodeId=478a140560801, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=Diabetes：与1型糖尿病患者糖尿病性视网膜病变有关的循环代谢物和脂质, objectType=article, longId=199951, objectId=a548199951b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a548199951b3, replyNumber=0, likeNumber=64, createdTime=2020-08-28, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a548199951b3, moduleTitle=Diabetes：与1型糖尿病患者糖尿病性视网膜病变有关的循环代谢物和脂质, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a548199951b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405607, encodeId=d897140560efc, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=VEGF-C/D（Opthea）和VEGF-A的双重靶向抑制：2a期临床证实显著提高糖尿病性视网膜病变患者的视力, objectType=article, longId=195644, objectId=8db11956440c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8db11956440c, replyNumber=0, likeNumber=68, createdTime=2020-06-12, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8db11956440c, moduleTitle=VEGF-C/D（Opthea）和VEGF-A的双重靶向抑制：2a期临床证实显著提高糖尿病性视网膜病变患者的视力, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8db11956440c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405606, encodeId=63491405606c9, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=李筱荣教授丨再谈糖尿病性视网膜病变诊治的几个问题, objectType=article, longId=179025, objectId=7d711e9025f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d711e9025f4, replyNumber=0, likeNumber=72, createdTime=2019-09-08, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d711e9025f4, moduleTitle=李筱荣教授丨再谈糖尿病性视网膜病变诊治的几个问题, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7d711e9025f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405605, encodeId=323e14056052e, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=Clin Sci (Lond)：糖尿病性视网膜病变发病机制的新途径- O-β-N-乙酰葡糖胺（O-GlcNAc）修饰, objectType=article, longId=128091, objectId=4f6d1280910d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f6d1280910d, replyNumber=0, likeNumber=63, createdTime=2018-01-30, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f6d1280910d, moduleTitle=Clin Sci (Lond)：糖尿病性视网膜病变发病机制的新途径- O-β-N-乙酰葡糖胺（O-GlcNAc）修饰, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4f6d1280910d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405604, encodeId=887214056041a, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=Front Biosci：使用SD-OCT图像可以对早期糖尿病性视网膜病变进行自动化检测！, objectType=article, longId=113871, objectId=5a151138e164, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a151138e164, replyNumber=0, likeNumber=83, createdTime=2017-09-24, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a151138e164, moduleTitle=Front Biosci：使用SD-OCT图像可以对早期糖尿病性视网膜病变进行自动化检测！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5a151138e164)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405603, encodeId=0cb11405603e1, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=Discov Med.：netrin-1在血管生成和糖尿病性视网膜病变中的作用：潜在治疗策略！, objectType=article, longId=106152, objectId=717f10615212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=717f10615212, replyNumber=0, likeNumber=84, createdTime=2017-07-22, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=717f10615212, moduleTitle=Discov Med.：netrin-1在血管生成和糖尿病性视网膜病变中的作用：潜在治疗策略！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=717f10615212)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405602, encodeId=64ee14056024a, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=糖尿病性视网膜病变，怎么办？, objectType=article, longId=101389, objectId=5f8510138939, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f8510138939, replyNumber=0, likeNumber=69, createdTime=2017-06-11, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f8510138939, moduleTitle=糖尿病性视网膜病变，怎么办？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5f8510138939)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405601, encodeId=f8f814056015d, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=糖尿病性视网膜病变的玻璃体手术, objectType=article, longId=64331, objectId=57a564331cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57a564331cd, replyNumber=0, likeNumber=81, createdTime=2016-03-08, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57a564331cd, moduleTitle=糖尿病性视网膜病变的玻璃体手术, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=57a564331cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405600, encodeId=67e31405600e5, content=<a href='/topic/show?id=b029e671390' target=_blank style='color:#2F92EE;'>#糖尿病性视网膜病变#</a>, objectTitle=JAMA：增生性糖尿病性视网膜病变治疗有了新选择, objectType=article, longId=58823, objectId=adf358823b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adf358823b8, replyNumber=0, likeNumber=65, createdTime=2015-11-16, rootId=0, userName=ligang4440, userId=a9522558089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adf358823b8, moduleTitle=JAMA：增生性糖尿病性视网膜病变治疗有了新选择, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=adf358823b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

糖尿病性视网膜病变

2020-05-29

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

Diabetes Care：胰高血糖素样肽1受体激动剂与糖尿病性视网膜病变发生风险的关系

2021-09-04

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

Diabetes：与1型糖尿病患者糖尿病性视网膜病变有关的循环代谢物和脂质

2020-08-28

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

VEGF-C/D（Opthea）和VEGF-A的双重靶向抑制：2a期临床证实显著提高糖尿病性视网膜病变患者的视力

2020-06-12

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

李筱荣教授丨再谈糖尿病性视网膜病变诊治的几个问题

2019-09-08

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

Clin Sci (Lond)：糖尿病性视网膜病变发病机制的新途径- O-β-N-乙酰葡糖胺（O-GlcNAc）修饰

2018-01-30

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

Front Biosci：使用SD-OCT图像可以对早期糖尿病性视网膜病变进行自动化检测！

2017-09-24

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

Discov Med.：netrin-1在血管生成和糖尿病性视网膜病变中的作用：潜在治疗策略！

2017-07-22

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

糖尿病性视网膜病变，怎么办？

2017-06-11

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

糖尿病性视网膜病变的玻璃体手术

2016-03-08

ligang4440 (审核中...)

前往app查看评论内容

#糖尿病性视网膜病变#

JAMA：增生性糖尿病性视网膜病变治疗有了新选择

2015-11-16

科室
- - 订阅+
  - 更多科室
工具
服务